跳至主要内容
临床试验/NCT05443451
NCT05443451已完成不适用

3D-Ultrasound-Guided Transperineal Microwave Needle Ablation for Men With Symptomatic Benign Prostatic Hyperplasia

Chinese University of Hong Kong2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2022年9月8日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
12
试验地点
2
主要终点
Adverse events (AE) and serious adverse events (SAE) related to the treatment

研究概览

简要总结

This is a pilot study on applying 3D-Ultrasound-Guided Transperineal Microwave needle ablation for men with symptomatic benign prostatic hyperplasia (BPH).

详细描述

This is a prospective, single centre, open-label and non-comparative trial planned on 12 patients. Patients who fit inclusion criteria would be recruited and offered microwave ablation to the enlarged prostate. The patients will be closely followed up to 6 months after treatment with serial assessment on safety and efficacy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Age over 50 years.
  • Benign prostatic hyperplasia with prostate size 30-80 cc
  • IPSS ≥ 14
  • PSA ≤ 4 ng/mL or PSA >4 ng/mL with no evidence of suspicious lesion on mpMRI
  • Maximum urine flow rate (Qmax) ≤ 15 mL/s.
  • Post-Void Residual ≤ 150 mL.
  • Patient suitable for IV sedation and/or spinal anaesthesia and/or general anaesthesia and focal microwave ablation.
  • Informed written consent

排除标准

  • Significant intravesical median lobe hyperplasia.
  • Suspicious lesion on mpMRI prostate
  • History of prostate, bladder or urethral surgery.
  • History of prostate cancer
  • Presence of stones, bladder diverticulum and/or bladder tumor
  • History of long-term indwelling catheter.
  • Urethral stricture
  • Known coagulopathy or on anticoagulant
  • Presence of a pacemaker.
  • Active infection
  • Dysuria due to bladder dysfunction.
  • Serious medical illness, including any of the following: uncontrolled congestive heart failure, uncontrolled angina, myocardial infarction, cerebrovascular event within 6 months prior to the screening visit.
  • Neurological disorders that would impact bladder function (e.g., multiple sclerosis, Parkinson's disease, spinal cord injury).
  • Contraindications for mpMRI exam or MR contrast
  • Acute and/or chronic renal failure (GFR <50 ml/min and serum creatinine > 1.5 mg/d).
  • Patient currently participating in another interventional clinical trial.

研究组 & 干预措施

Transperineal Microwave needle ablation for symptomatic BPH

Experimental

干预措施: 3D-Ultrasound-Guided Transperineal Microwave needle ablation of BPH (Device)

结局指标

主要结局

Adverse events (AE) and serious adverse events (SAE) related to the treatment

时间窗: At 1 month

The severity of AE is grade by Clavien-Dindo classification.

次要结局

  • Ablation treatment time(Intra-operation)
  • Ease of the procedure measured with a score chosen by the operator(Post procedure immediately)
  • Patient quality of life(Baseline, 1-week, 1-month, 3-month, and 6-month,)
  • Erectile function measured by International Index of Erectile Function 5-item version (IIEF-5) score(Baseline, 1 month, 3 months, 6 months)
  • Change in urodynamic in uroflowmetry(Baseline, 1 month, 3 months, 6 months)
  • Average patient post-operative pain level(Baseline, 2 and 4 hours after the procedure and at 1-week)
  • Prostate volume change(Baseline, 3 months, 6 months)
  • Urinary symptoms measured by International Prostate Symptom Score (IPSS) score(Baseline, 1 month, 3 months, 6 months)
  • Ejaculatory function measured by MSHQ-EjD-SF (function and bother) score(Baseline, 1 month, 3 months, 6 months)
  • PSA change(Baseline, 3 months, 6 months)
  • Patient satisfaction(Baseline, 1-week, 1-month, 3-month, and 6-month,)
  • Length of hospital stay(The total number of days of hospitalization for this surgical procedure up to day 30 after the procedure])
  • Operation time(Intra-operation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

CHIU Ka Fung Peter

Associate Professor

Chinese University of Hong Kong

研究点 (2)

Loading locations...

相似试验